Dr Lee Han Jie

Lee Han Jie is an Associate Consultant Urologist with Singapore General Hospital. He was awarded his Bachelor of Medicine and Bachelor of Surgery (MBBS) from the National University of Singapore (NUS) in 2015 as part of the Dean’s List, and was admitted as a member in the Royal College of Surgeons of Edinburgh in 2016. He completed his Urology residency in 2025 being awarded the College of Surgeons Gold Medal as the top-performing surgical trainee in Urology, and he was not only among the top 3 chief residents in his cohort, but was named the Valedictorian of his graduating batch of Singhealth specialists.

A passionate clinician, Dr Lee is heavily involved in clinical research and has published extensively, including in high-impact journals like Lancet Oncology and European Urology. With a keen interest in medical innovation, he has been involved in several grants for the development of medical devices and was one of the youngest specialists to receive the prestigious National Medical Research Council (NMRC) Clinician-Innovator Award.

Dr Lee is experienced in the management of a spectrum of urological conditions, but has a keen subspecialty interest in urological stone diseases, lower urinary tract symptoms, prostate enlargement and minimally-invasive surgery. He is heavily invested in the care of his patients, which have been exemplified in commendations such as Service with a Heart award, and multiple Service Excellence Awards.

• FRCS (Glasgow), 2025
• FAMS (Urol), 2025
• DWD (CAW), 2017
• MRCS (Edinburgh), 2016
• MBBS (Singapore), 2015

• College of Surgeons Gold Medal Award in Urology, 2026
• Singapore Urological Association Gold Medallist Scholarship, 2026
• Clinician Innovator Award, National Medical Research Council, 2026
• Best Clinical Service Innovation Team Award, 2025
• Singhealth Appropriate and Value-Based Care (AVBC) – Most improved VDC Award, 2025
• Valedictorian, Singhealth Residency, 2025
• Outstanding Resident Award, RiSE Awards, 2025
• Outstanding Chief Resident Award, SingHealth GME, 2025
• Service Excellence Award, Division of Surgery and Surgical Oncology (DSSO), 2025
• Outstanding Resident Award, RiSE Awards, 2024
• Singhealth Publish! Award, 2024
• Outstanding Resident Award, RiSE Awards, 2023
• Service Excellence Award, Division of Surgery and Surgical Oncology (DSSO), 2022
• Singhealth Education Office Teaching Award, 2022
• NUS Medicine Junior Doctor Teaching Award, 2020
• Singhealth Service with a Heart Award, 2019
• Singhealth Best House Officer Award, 2016
• Dean's List, 2014
  

1. Lee HJ*, Yaow C*, Chong RIH, Kelzang S, Gauhar V, Yuen SKK, Low AWX, Sundaram P, Zhu W, Zeng GH, Chong TW, Du JZ. RIRS with Flexible and Navigable Suction Access Sheaths vs mini-PCNL for large upper urinary tract stones: A Systematic Review and Meta-Analysis. BJU Int. 2026;
2. Fong KY*, Lee HJ*, Yeap P, Du JZ, Low AWX, Chong TW, Sundaram P.
3. Thulium Fiber Laser versus High-Power Holmium Laser for Renal Stones: A Systematic Review and Meta-Analysis of High-Quality Studies. Therapeutic Advances in Urology. 2026;18.
4. Yu L, Lee A, Teh MW, Loh E, Brodie B, Saiduzzaman BM, Lee HJ, Tan YG, Tay KJ, Ho HSS, Yuen JSP, Chen K. Evaluating learning curves and robotic skill transfer to hinotori: CUSUM analysis after complete platform conversion in radical prostatectomy. World J Urol 2026, 44, 265.
5. Lau R, Lee HJ, Fung KY, Lee A, Tan YG, Law YM, Ngo T, Tuan J, Tay KJ, Lee LS, Cheng C, Ho H, Yuen J, Chen K. Real World Prevalence of Lymph Node Involvement in Prostate Cancer in Asia: Do We Need a Rethink on Nomograms? Front. Oncol 2025 15:1583806.
6. Lee HJ, Tay YJJ, Ye S, Khoo PF, Ho KCH, Tang GF, Tan M, Chia SY, Tan MSK, Lee LS. An Automated System for Tracking, Recording and Reminding for Medical Implants (TRACER) – A Pilot Study with Ureteric Stents. J Endourol. 2025, 2025 Apr;39(4):343-348.
7. Lee HJ, Lim EJ, Woo SJQ, Aslim EJ, Ng LG, Gan VHL. De Novo Urological Malignancies after Renal Transplantation: an Asian 30-year experience. Clin. Transpl 2024, Jul;38(7):e15415
8. Yaow C*, Lee HJ*, Teoh S, Chong RIH, Ng TK, Tay KJ, Ho H, Law YM, Yuen JSP, Chen K. Local Therapy on Clinically Lymph Node-positive Prostate Cancer: A Systematic Review and Meta-Analysis. Eur Urol Oncol 2023, Sep 18:S2588-9311(23)00175
9. Chow KM, So WZ, Lee HJ, Lee A, Yap DWT, Takwoingi Y, Tay KJ, Tuan J, Sue PT, Lan W, Yuen J, Lawrentschuk N, Hofman M, Murphy D, Chen K. Head-to-head Comparison of the Diagnostic Accuracy of Prostate-Specific Membrane Antigen Positron Emission Tomography and Conventional Imaging Modalities for Initial Staging of Intermediate- to High-risk Prostate Cancer: A Systematic Review and Meta-Analysis. Eur Urol 2023, Jul;84(1):36-48. doi: 10.1016/j.eururo.2023.03.001
10. Lee HJ, Aslim E, Balamurali BT, Ng LYS, Kuo TLC, Lim KS, Lin CMY, Clarke CJ, Priyadarshinee P, Chen JM, Ng LG. Development and Validation of a Deep Learning System for Sound-based Prediction of Urinary Flow. Eur Urol Focus 2023 Jan;9(1):209-215
11. Lee A, Chen K, Tan YG, Lee HJ, Shutchaidat V, Chong S, Cheng CWS, Ho HSS, Yuen JSP, Ngo NT, Law YM, Tay KJ. Reducing the number of systematic biopsy cores in the era of MRI targeted biopsy—implications on clinically-significant prostate cancer detection and relevance to focal therapy planning. Prostate Cancer Prostatic Dis 25, 720–726 (2022)
12. Teo XL, Lee HJ, Lim SK. Will not bagging an excised tumour immediately during partial nephrectomy possibly result in tumour seeding? A case report. Laparoscopic, Endoscopic and Robotic Surgery 2022.5(3):128-130
13. Lee HJ, Ong HL, Ng TK, Yap TL. Urothelial Carcinoma in a child with gross hematuria – a complaint not to be dismissed. BMJ Case Reports 2021. 14:e247239
14. Lee A, Yang XY, Lee HJ, Law YM, Huang HH, Lau WKO, Lee LS, Ho H, Tay KJ, Cheng CWS, Yuen JSP, Chen K. Limitations of overlapping cores in systematic and MRI-US fusion biopsy. Urol Oncol 2021. 39(11):782.e15–782.e21
15. Lee HJ, Lee A, Yang XY, Law YM, Huang HH, Lau WKO, Lee LS, Ho H, Tay KJ, Cheng CWS, Yuen JSP, Chen K. External validation and comparison of magnetic resonance imaging-based predictive models for clinically significant prostate cancer. Urol Oncol 2021; 39(11):783.e1-783.e10
16. Lee A, Yang XY, Lee HJ, Law YM, Huang HH, Lau WKO, Lee LS, Ho H, Tay KJ, Cheng CWS, Yuen JSP, Chen K. Multiparametric MRI‐ultrasonography software fusion prostate biopsy: initial results using a stereotactic robotic‐assisted transperineal prostate biopsy platform comparing systematic vs targeted biopsy. BJU Int. 2020 Nov;126(5):568-576
17. Lee HJ, Lee A, Tan D, Du J, Wang Y, Tang PY, Sim A. Cutaneous metastasis of renal cell carcinoma. Lancet Oncol 2020. 21(5):e292
18. JSM Teo, Lee HJ, Yuen SPJ. Perioperative anticoagulation and open distal corpora cavernosa shunt in the management of a case of stuttering idiopathic persistent childhood ischaemic priaprism. Asian J Urol. 2019. 8(4):436-439
19. Lee A, Lee HJ, Huang HH, Tay KJ, Lee LS, Sim SPA, Ho SSH, Yuen SPJ, Chen K. Prognostic Significance of Inflammation-associated Blood Cell Markers in Nonmetastatic Clear Cell Renal Cell Carcinoma. Clin Genitourin Cancer. 2019; 18(4):304–313
20. Chin KM, Lee SQW, Lee HJ, Ping CS, Ch’ng JK. Preservation of Stent-Graft after Iatrogenic Type III Endoleak during Open Transperitoneal Surgical Intervention for Complicated Type II Endoleak. Ann. Vasc. Surg. 2020; 62:496.e1-496.e7
21. Lee HJ, Chin KM, Lee Shaun, Yap HY, Ch’ng JK, Chng SP, Tay HS. Maximally Disfiguring Surgery for Forefoot Osteomyelitis – Time for a Rethink? Int J Low Extrem Wounds. 2020 Mar; 19(1):99–104.
22. Lee A, Lee HJ, Huang HH, Ho H, Chen K. Low-risk non-muscle-invasive bladder cancer: Further prognostic stratification into the “very-low-risk” group based on tumour size. Int. J. Urol, 2019; 26(4):481-486
23. Lee HJ, Lee A, Huang HH, Lau WKO. External validation of the updated Leibovich prognostic models for clear cell and papillary renal cell carcinoma in the Asian population. Urol Oncol. 2019; 37(6):356.e9-356.e.18
24. Lee HJ, Chen K, Molchanov R, Schwentner C and Sim AS, Feasibility of utilizing near‐infrared fluorescence imaging with indocyanine green for super‐selective arterial clamping in pure laparoscopic partial nephrectomy. Int. J. Urol, 2018; 25: 382-383
25. Lee HJ, Lee A, Huang HH, Lau WKO. Primary androgen deprivation therapy as monotherapy in unfavourable intermediate- and high-risk localised prostate cancer: a Singaporean single-centre perspective. Int Urol Nephrol. 2018; 50: 665
26. Lee A, Lee HJ, Foo KT. Can men with prostates sized 80 mL or larger be managed conservatively? Investig Clin Urol. 2017; 58(5): 359-364
27. Lee A, Lee HJ, Lim KB, Huang HH, Ho H, Foo KT. Can intravesical prostatic protrusion predict bladder outlet obstruction even in men with good flow?. Asian J Urol. 2015; 3(1): 39-43
28. Lee HJ, Lee A, Huang HH, Sundaram P, Foo KT. Patients with small prostates and low-grade intravesical prostatic protrusion - A urodynamic evaluation. Asian J Urol. 2017; 4(4): 247-252